Claudio Hidalgo new CSO-CEO in Microviable Therapeutics

We are happy to welcome Claudio Hidalgo Cantabrana in our team as former CSO-CEO.

Claudio did his PhD in microbial genetics working in #probiotics, microbiome and human health, with several international internships in research institutions and industry.

After his work in the US, he came back to lead our team, strengthen our capabilities and advance our platforms on #microbiome and next generation probiotics.